Group 1: Financial Performance - In Q1 2025, the company's revenue increased by 5.91% year-on-year, while net profit grew by 9.70% and non-recurring net profit rose by 23.26% [2] - R&D investment for 2024 reached 74.4481 million, marking a 21.07% increase compared to the previous year [8] Group 2: Business Expansion Strategies - The company plans to expand its digital healthcare services, focusing on "remote pathology diagnosis + AI assistance" [2] - The smart optics division aims to enhance its capabilities in precision detection and expand into industrial applications [12] - The intelligent electrical segment will deepen its applications in new energy and rail transportation, reinforcing its industry leadership [3] Group 3: Cost Control Measures - The company will strengthen comprehensive budget management and enhance production efficiency through smart manufacturing upgrades [5] - Supply chain management and lean production practices will be optimized to reduce costs [5] Group 4: Market Position and Competitive Advantages - The company is among the few global manufacturers with full voltage level capabilities in the intelligent electrical sector, maintaining a strong position alongside international leaders [7] - The smart optics division is a leading player in the domestic microscope market, with products distributed across 109 countries [7] - The digital healthcare platform covers over 3,000 hospitals, having completed over one million diagnoses [7] Group 5: Challenges and Future Outlook - External factors affecting growth include geopolitical conflicts, accelerated technological iterations, and trade barriers [10] - The company is actively researching strategies to mitigate the impact of currency fluctuations on profits, particularly in emerging markets [11] - Plans for potential adjustments in dividend policies or share buybacks will be based on specific circumstances [12]

麦克奥迪（300341）公告，股东麦克奥迪控股有限公司和香港协励行有限公司计划自公告发布之日起15 个交易日后的3个月内，通过大宗交易或集中竞价方式分别减持公司股份1241.78万股，合计减持股份占 公司总股本比例2.4%。减持原因是股东自身经营计划需要，减持价格将根据市场价格确定。 ...

证券代码：300341 证券简称：麦克奥迪 公告编号：2025-019 麦克奥迪（厦门）电气股份有限公司 关于公司股东减持股份预披露公告 麦克奥迪控股有限公司、香港协励行有限公司保证向本公司提 供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供 的信息一致。 特别提示： 持有本公司股份 79,391,022 股（占本公司总股本比例 15.34%）的股东麦克 奥迪控股有限公司计划自本公告发布之日起 15 个交易日后的 3 个月内以大宗交 易方式或集中竞价方式减持本公司股份 12,417,848 股（占本公司总股本比例 2.4%）。 持有本公司股份 48,576,998 股（占本公司总股本比例 9.39%）的股东香港协 励行有限公司计划自本公告发布之日起 15 个交易日后的 3 个月内以大宗交易方 式或集中竞价方式减持本公司股份 12,417,848 股（占本公司总股本比例 2.4%）。 截至本公告日，公司股东麦克奥迪控股有限公司持有公司股份 79,391,022 股， 占公司总股本比例的 15.34%；公司股东香港协励行有限公司持有公司股 ...

麦克奥迪（厦门）电气股份有限公司 关于参加厦门辖区上市公司2024年年报业绩说明会暨 投资者网上集体接待日活动的公告 证券代码：300341 证券简称：麦克奥迪 公告编号：2025-018 本公司及董事会全体成员保证信息披露内容的真实、准确和完 1 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP,参与 本次互动交流，活动时间为 2025 年 5 月 15 日（周四）15:40-17:00。届时公司高 管将在线就公司 2024 年度业绩、公司治理、发展战略、经营状况、融资计划、 股权激励和可持续发展等投资者关心的问题，与投资者进行沟通与交流，欢迎广 大投资者踊跃参与！ 特此公告。 麦克奥迪（厦门）电气股份有限公司 董事会 2025 年 04 月 29 日 整，没有虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，麦克奥迪（厦门）电气股份有限公司（以 下简称"公司"）将参加由厦门证监局、厦门上市公司协会与深圳市全景网络有 限公司联合举办的"厦门辖区上市公司 2024 年年报业绩说明会暨投资者 ...

| 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0674 | 0.0615 | 9.59 | 0.0759 | | 每股净资产（元） | 3.58 | 3.32 | 7.83 | 3.1 | | 每股公积金(元) | 0.11 | 0.14 | -21.43 | 0.13 | | 每股未分配利润(元) | 2.29 | 2.05 | 11.71 | 1.88 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 3.16 | 2.98 | 6.04 | 3.49 | | 净利润(亿元) | 0.35 | 0.32 | 9.37 | 0.39 | | 净资产收益率(%) | 1.90 | 1.87 | 1.6 | 2.47 | 数据四舍五入，查看更多财务数据>> 一、主要会计数据和财务指标 | 名称 | 持有数量(万股) | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | ...

麦克奥迪（厦门）电气股份有限公司《2025 年第一季度报告全文》已于 2025 年 04 月 28 日在中国证监会指定的创业板信息披露网站上披露，请投资者注意查 阅！ 特此公告。 麦克奥迪（厦门）电气股份有限公司 董事会 2025 年 04 月 28 日 1 证券代码：300341 证券简称：麦克奥迪 公告编号：2025-017 麦克奥迪（厦门）电气股份有限公司 2025年第一季度报告披露提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥315,958,512.39, representing a 5.91% increase compared to ¥298,315,173.81 in the same period last year[5]. - Net profit attributable to shareholders was ¥34,881,605.21, up 9.70% from ¥31,797,928.74 year-on-year[5]. - The net profit after deducting non-recurring gains and losses increased by 23.26%, reaching ¥33,198,617.93 compared to ¥26,934,371.07 in the previous year[5]. - Basic and diluted earnings per share were both ¥0.0674, reflecting a 9.59% increase from ¥0.0615[5]. - The net profit for the current period is 34,126,001.32, an increase from 33,316,637.64 in the previous period, representing a growth of approximately 2.43%[20]. - The total profit for the current period is 39,731,667.24, compared to 40,618,242.94 in the previous period, indicating a decrease of about 2.18%[20]. - The operating profit for the current period is 39,838,461.59, slightly up from 38,777,992.68, reflecting an increase of approximately 2.73%[20]. - The total comprehensive income attributable to the parent company is 33,649,868.18, compared to 29,066,652.25 in the previous period, reflecting an increase of approximately 15.5%[21]. Cash Flow - The net cash flow from operating activities decreased significantly by 59.97%, amounting to ¥31,704,022.14, down from ¥79,197,650.96 in the same period last year[5]. - The cash flow from operating activities is 31,704,022.14, down from 79,197,650.96 in the previous period, a decline of about 60%[22]. - The cash flow from investing activities shows a net outflow of -19,807,398.98, compared to -17,684,715.00 in the previous period, indicating a higher outflow of about 12%[23]. - The net cash flow from investing activities was -¥1,980.74 million, reflecting a 12.00% increase in fixed asset investments compared to -¥1,768.47 million last year[10]. - The net cash flow from financing activities decreased by 33.37%, totaling -¥170.29 million compared to -¥255.59 million in the previous year[10]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,576,236,635.75, a 1.48% increase from ¥2,538,704,154.72 at the end of the previous year[5]. - Total liabilities increased to ¥604,836,669.78 from ¥600,352,967.81, a rise of 0.8%[18]. - The company's total equity at the end of the period was ¥1,971,399,965.97, compared to ¥1,938,351,186.91, showing an increase of 1.7%[18]. - The company's cash and cash equivalents at the end of the period were ¥838,129,647.30, slightly up from ¥823,718,548.95 at the beginning of the period[16]. - Accounts receivable rose to ¥598,175,589.63 from ¥575,320,806.96, indicating an increase of 3.0%[16]. - Inventory levels increased to ¥336,829,971.94, compared to ¥318,562,828.21, reflecting a growth of 5.7%[16]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 35,773[11]. - The largest shareholder, Beijing Yizhuang Investment Holding Co., Ltd., holds 29.57% of shares, totaling 152,997,984 shares[11]. - The second largest shareholder, Macquarie Group Limited, holds 15.34% of shares, totaling 79,391,022 shares[11]. - The third largest shareholder, Hong Kong Xielihang Limited, holds 9.39% of shares, totaling 48,576,998 shares[11]. - The total number of restricted shares held by executives at the end of the period is 2,041,800 shares[12]. - The company has no preferred shareholders or changes in preferred shareholder holdings to report[12]. - The company has not reported any changes in the top 10 shareholders due to securities lending[12]. - The total number of shareholders with voting rights restored for preferred shares is 0[11]. Accounting Policy Changes - The company will implement the new accounting policy starting from the 2024 fiscal year, affecting sales expenses and operating costs[13]. - The impact of the new accounting policy on sales expenses for Q1 2025 is a decrease of 1,062,441.85, while for Q1 2024 it is a decrease of 633,067.23[15]. Operating Costs - Total operating costs amounted to ¥275,393,925.35, up from ¥263,228,577.16, reflecting a year-over-year increase of 4.5%[19]. - Research and development expenses increased significantly to ¥21,132,053.76, compared to ¥15,736,162.65 in the previous period, marking a growth of 34.1%[19]. - The income tax expense for the current period is 5,605,665.92, down from 7,301,605.30 in the previous period, representing a decrease of about 23.2%[20].

Core Insights - 麦克奥迪在2024年实现营业总收入13.54亿元，同比下降0.86%；归属净利润1.61亿元，同比下降4.34% [1] - 公司在数智医疗、智慧光学和智能电气三大业务板块中持续推进技术创新和市场拓展，但整体业绩表现疲软，净利润连续两年下滑 [1] Smart Healthcare - 数智医疗板块是公司的核心业务之一，围绕数字病理远程诊断与质控平台展开，2024年累计完成超百万例远程诊断，服务覆盖近3,000家医院 [4] - 尽管业务扩展迅速，数智医疗板块的业绩因行业政策变化和市场需求调整而承压，盈利能力受到影响 [4] Smart Optics - 智慧光学板块专注于智能光学设备的研发、生产和销售，2024年在全球范围内推广智能光学设备，保持国内市场占有率第一 [5] - 尽管在全球市场取得进展，智慧光学板块的营收和利润增速均有所下降，反映出市场竞争加剧和需求波动的压力 [5][6] Smart Electrical - 智能电气板块专注于环氧绝缘件的研发与制造，2024年高压产品收入同比增长24%，国内高压收入增长28% [7] - 尽管高压产品领域取得显著增长，整体业绩仍显疲软，营收和利润增速均有所下降，面临市场竞争加剧和需求波动的挑战 [7] Overall Performance - 公司在2024年通过优化资源配置、强化技术创新和数字化转型，持续推进高质量发展，但三大业务板块的业绩表现均显疲软，反映出复杂宏观环境下的经营压力 [7]

证券代码：300341 证券简称：麦克奥迪 公告编号：2025-007 非标准审计意见提示 □适用 √不适用 公司上市时未盈利且目前未实现盈利 所有董事均已出席了审议本报告的董事会会议。 立信会计师事务所（特殊普通合伙）对本年度公司财务报告的审计意见为：标准的无保留意见。 本报告期会计师事务所变更情况：公司本年度会计师事务所由变更为立信会计师事务所（特殊普通合 伙）。 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 √适用 □不适用 一、重要提示 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者 应当到证监会指定媒体仔细阅读年度报告全文。 公司经本次董事会审议通过的利润分配预案为：以517,410,336为基数，向全体股东每10股派发现金红利 0.7元（含税），送红股0股（含税），以资本公积金向全体股东每10股转增0股。 董事会决议通过的本报告期优先股利润分配预案 □适用 □不适用 二、公司基本情况 1、公司简介 ■ 2、报告期主要业务或产品简介 数智医疗聚焦数字病理全价值链，构建"线上诊断+线下服务"一体化生态。公司以卫健委数字病理平台 为依托 ...

麦克奥迪（厦门）电气股份有限公司 内部控制审计报告 2024 年度 目 录 内部控制审计报告 第 1 -2 页 内部控制审计报告 信会师报字[2025]第 ZB10476 号 麦克奥迪（厦门）电气股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相 关要求，我们审计了麦克奥迪（厦门）电气股份有限公司（以下简称 麦克奥迪）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、 企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企 业内部控制评价指引》的规定，建立健全和有效实施内部控制，并评 价其有效性是麦克奥迪董事会的责任。 二、 注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的 有效性发表审计意见，并对注意到的非财务报告内部控制的重大缺陷 进行披露。 三、 内部控制的固有局限性 内部控制具有固有局限性，存在不能防止和发现错报的可能性。 内控审计报告第 1 页 中国注册会计师： 中国•上海 2025 年 4 月 17 日 内控审计报告第 2 页 此外，由于情况的变化可能导致内部控制变得不恰当，或对控制 政策和程序遵循 ...